https://pubmed.ncbi.nlm.nih.gov/34276680/
AID and APOBECs as Multifaceted Intrinsic Virus-Restricting Factors: Emerging Concepts in the Light of COVID-19
- PMID: 34276680
- PMCID: PMC8282206
- DOI: 10.3389/fimmu.2021.690416
Free PMC article
The AID (activation-induced cytidine deaminase)/APOBEC (apolipoprotein B mRNA editing enzyme catalytic subunit) family with its multifaceted mode of action emerges as potent intrinsic host antiviral system that acts against a variety of DNA and RNA viruses including coronaviruses. All family members are cytosine-to-uracil deaminases that either have a profound role in driving a strong and specific humoral immune response (AID) or restricting the virus itself by a plethora of mechanisms (APOBECs). In this article, we highlight some of the key aspects apparently linking the AID/APOBECs and SARS-CoV-2. Among those is our discovery that APOBEC4 shows high expression in cell types and anatomical parts targeted by SARS-CoV-2. Additional focus is given by us to the lymphoid structures and AID as the master regulator of germinal center reactions, which result in antibody production by plasma and memory B cells. We propose the dissection of the AID/APOBECs gene signature towards decisive determinants of the patient-specific and/or the patient group-specific antiviral response. Finally, the patient-specific mapping of the AID/APOBEC polymorphisms should be considered in the light of COVID-19.
Keywords: AID; AID/APOBECs gene expression signature; APOBEC4; APOBECs; COVID-19; SARS-CoV-2; germinal center; lymphoid structures.
-
Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.Sci Adv. 2020 Jun 17;6(25):eabb5813. doi: 10.1126/sciadv.abb5813. eCollection 2020 Jun. PMID: 32596474 Free PMC article.
-
The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.Sci Rep. 2022 Sep 13;12(1):14972. doi: 10.1038/s41598-022-19067-x. PMID: 36100631 Free PMC article.
-
The role of A-to-I RNA editing in infections by RNA viruses: Possible implications for SARS-CoV-2 infection.Clin Immunol. 2021 May;226:108699. doi: 10.1016/j.clim.2021.108699. Epub 2021 Feb 25. PMID: 33639276 Free PMC article. Review.
Inga kommentarer:
Skicka en kommentar